Can a biosynthetic pathway be a new route to antibiotic use?
Scientists have discovered a new route to antibiotic use, exploiting a chemical process and gene editing, also known as a biosynthetic pathway.
Researchers from The...
Concomitant use of benzodiazepine drugs common amongst AD patients
The most commonly concomitant use amongst AD patients was benzodiazepine drugs and a weak opioid – where one in five people with Alzheimer’s disease...
Levels of opioid misuse may be dependent on sexual orientation
According to NYU School of Medicine, men and women identifying as lesbian, gay, or bisexual are at a higher risk of opioid misuse compared...
Medical benefits of cannabis may be less effective than the liverwort plant
For the first time researchers have found that the substance found in the liverwort plant could have the medical benefits of cannabis, and perhaps...
5th Precision Medicine and Biomarkers Leaders Summit: Europe
Health Europa listened to InnVentis CEO Thomas Wilckens discuss some of the diagnostic and data challenges involved in precision medicine.
The 5th Precision Medicine and...
Michael Lisanti and antibiotics: the next cancer revolution
Speaking to Health Europa, Professor Michael Lisanti, MD-PhD, FRSA discusses the potential role of antibiotics in preventing the recurrence of cancer.
How would you cure...
From highly priced medicines to Medicines That Matter
Highly priced medicines represent a significant public health challenge. Global health advocate Ella Weggen shares how Wemos is responding through its dedicated project Medicines...
BioBlocks, Inc.: Transforming the process of lead discovery
BioBlocks CEO Dr Peter Pallai discusses how BioBlocks is making drug discovery more straightforward, faster and more economical using data-driven approaches.
BioBlocks is a medicinal...
Open Targets – transforming drug discovery
Health Europa talks with Open Targets who discuss how the platform works to systematically identify and prioritise drug discovery to develop safe and effective...
Cocaine contaminant, levamisole, may cause brain damage
Individuals who regularly take the cocaine contaminant, levamisole, demonstrate impaired cognitive performance & a thinned prefrontal cortex.
Recent findings from the University of Zurich, Switzerland, indicate...
Prudenta: an electronic solution for local literature monitoring in pharmacovigilance
Dr Polina Dombure, the managing director of Inpharmatis, introduces Prudenta, an innovative pharmacovigilance solution set to transform local literature monitoring.
The costly, time-consuming and error-prone...
Assessing the environmental risk of pharmaceuticals
AstraZeneca’s Jason Snape, outlined his company’s approach to the environmental risk assessment of human medicinal products and what more needs to be in place...
Challenges and opportunities in cancer drug development
Managing director Professor Heinz Zwierzina of the Cancer Drug Development Forum talks Health Europa through the challenges in the search for new cancer drugs.
The...
Pharmacovigilance in the EU: a closer look at EudraVigilance
Health Europa highlights the role of EudraVigilance in the pharmacovigilance activities of the EMA, from the launch of the revamped system in 2017 to...
Learning from Nature: understanding sustainable antibiotic use
There is a pressing need to better understand sustainable antibiotic use and the evolution of resistance in infectious diseases.
The evolution of antibiotic-resistant pathogens poses...
Michael Lisanti and his focus on doxycycline antibiotics
Health Europa delves further into Lisanti’s successful breast cancer clinical trial and the remarkable use of doxycycline antibiotics.
Lisanti and his wife Professor Sotgia, from...
New targeted methotrexate underway for rheumatoid arthritis
ROS Therapeutics APS has developed a targeted methotrexate prodrug to mitigate the side effects experienced by many rheumatoid arthritis patients.
Danish start-up company ROS Therapeutics...
What do you know about the Danish medical cannabis pilot programme?
Minister of Health, Ellen Trane Nørby, provides insight into the recently introduced Danish medical cannabis pilot programme and its implications.
What does the Danish medical...
CAR T-cell therapies in Europe
Health Europa reflects on the first two CAR T-cell therapies to have been recommended for approval in the European Union.
In June, the European Medicines...
Prescription cannabis in UK: have the law and the drug become best buds?
The UK government has announced that patients can receive prescription cannabis by specialist doctors from 1 November 2018.
Health Europa previously reported upon the review...
